Literature DB >> 24666704

Candidemia surveillance in Iowa: emergence of echinocandin resistance.

Eiyu Matsumoto1, Linda Boyken2, Shailesh Tendolkar2, Jennifer McDanel2, Mariana Castanheira3, Michael Pfaller4, Daniel Diekema5.   

Abstract

We performed prospective surveillance for candidemia at 14 Iowa hospitals in 2011-2012. A total of 163 episodes were analyzed. Candida albicans (n = 69 [42%]) and Candida glabrata (n = 58 [36%]) were the most common species. Antifungal resistance was uncommon; 9% of C. glabrata were fluconazole resistant, and 5% (3 isolates) were intermediate or resistant to 1 or more of the echinocandins. Molecular analyses of the fks1 and fks2 hotspots of the C. glabrata revealed no mutations except in 2 of these 3 isolates (L628R and S629P in fks1). Compared with previous surveillance performed in 1998-2001, there was a decrease in proportion of candidemia due to C. albicans (58 to 42%) and an increased proportion due to C. glabrata (20 to 36%). Further emergence of echinocandin resistance among the increasingly common species C. glabrata would complicate the management of this life-threatening infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antifungal resistance; Bloodstream infection; Candida; Echinocandin; Surveillance

Mesh:

Substances:

Year:  2014        PMID: 24666704     DOI: 10.1016/j.diagmicrobio.2014.02.016

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  18 in total

1.  Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.

Authors:  Brunella Posteraro; Teresa Spanu; Barbara Fiori; Flavio De Maio; Elena De Carolis; Alessia Giaquinto; Valentina Prete; Giulia De Angelis; Riccardo Torelli; Tiziana D'Inzeo; Antonietta Vella; Alessio De Luca; Mario Tumbarello; Walter Ricciardi; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

2.  In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations.

Authors:  Natalie S Nunnally; Kizee A Etienne; David Angulo; Shawn R Lockhart; Elizabeth L Berkow
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.

Authors:  Laura Bedin Denardi; Jéssica Tairine Keller; Vanessa Oliveira; Débora Alves Nunes Mario; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2017-05-10       Impact factor: 2.574

Review 4.  Azole Resistance in Candida glabrata.

Authors:  Sarah G Whaley; P David Rogers
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

5.  Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.

Authors:  Yali Gao; Mingsui Tang; Yaling Li; Xueli Niu; Jingyi Li; Chang Fu; Zihan Wang; Jiayi Liu; Bing Song; Hongduo Chen; Xinghua Gao; Xiuhao Guan
Journal:  PeerJ       Date:  2022-06-15       Impact factor: 3.061

6.  Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.

Authors:  Laura Milazzo; Anna Maria Peri; Cristina Mazzali; Romualdo Grande; Chiara Cazzani; Davide Ricaboni; Antonio Castelli; Ferdinando Raimondi; Carlo Magni; Massimo Galli; Spinello Antinori
Journal:  Mycopathologia       Date:  2014-07-24       Impact factor: 2.574

Review 7.  Echinocandin resistance: an emerging clinical problem?

Authors:  Maiken C Arendrup; David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

8.  Antifungal Susceptibility of Clinical Yeast Isolates from a Large Canadian Reference Laboratory and Application of Whole-Genome Sequence Analysis To Elucidate Mechanisms of Acquired Resistance.

Authors:  Lisa R McTaggart; Ana Cabrera; Kirby Cronin; Julianne V Kus
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

9.  Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.

Authors:  Maria Teresa Montagna; Grazia Lovero; Caterina Coretti; Domenico Martinelli; Osvalda De Giglio; Roberta Iatta; Stella Balbino; Antonio Rosato; Giuseppina Caggiano
Journal:  BMC Microbiol       Date:  2015-05-20       Impact factor: 3.605

10.  Invasive Candidiasis Species Distribution and Trends, United States, 2009-2017.

Authors:  Emily E Ricotta; Yi Ling Lai; Ahmed Babiker; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; D Rebecca Prevots; Jennifer Adjemian
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.